Ranbaxy & Merck to jointly discover novel antibiotic molecule

After collaborating with Advinus therapeutics ( Tata group company) to discover and work on drugs for metabolic disorders and Nicholas Piramal (Anticancer drugs), The pharma giant Merck has now collaborated with Ranbaxy for novel antibiotic research. Ranbaxy Ltd. and Merck & Co., Inc have signed a strategic Product Development Agreement for a drug discovery and clinical development collaboration for new products, in the anti-infective field. Ranbaxy and Merck will work together to develop clinically effective anti-bacterial and anti-fungal drug candidates. Ranbaxy will carry-out drug discovery and clinical development through phase IIa clinical trials, with Merck conducting development and commercialization of drug candidates thereafter.
India is a good outsourcing destination for innovator companies. In recent times, some pharma companies have outsourced their work to Indian pharmaceutical companies.